1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cetuximab (SCCHN): new trials by email Literature Review of Cetuximab (SCCHN) trials Research Report on Cetuximab (SCCHN)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 and 2 Study of PX-866 and Cetuximab PX-866 (SCCHN), Cetuximab (SCCHN), PX-866 (CRC) - Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | Phase 1 / Phase 2 | Completed | Cascadian Therapeutics Inc. | 178 | 2010-12-01 | 2018-05-16 |
Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Recurrence (1)
Cascadian Therapeutics Inc. (1)
Canada (1) · United States (1)